Trademark applications and grants for Leo Pharma A S. Leo Pharma A S has 93 trademark applications. The latest application filed is for "ANZUPGO (DELGOCITINIB)"
Patent Application | Date |
---|---|
TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS 20220241284 - 17/610787 NIELSEN; Jacob ;   et al. | 2022-08-04 |
SMALL MOLECULE MODULATORS OF IL-17 20220162191 - 17/436885 LIANG; Xifu ;   et al. | 2022-05-26 |
TREATMENT OF ALOPECIA AREATA 20220088020 - 17/228831 SIERRA; Michael ;   et al. | 2022-03-24 |
NOVEL AMINO-IMIDAZOPYRIMIDINE DERIVATIVES AS JANUS KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF 20210269447 - 17/257905 LARSEN; Jens C. Hojland ;   et al. | 2021-09-02 |
METHODS FOR THE PREPARATION OF 1,3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS 20210147440 - 16/624491 DAHL; Allan Carsten ;   et al. | 2021-05-20 |
CAGE Code | R0097 | LEO PHARMA A/S |
SEC | 0001471790 | LEO Pharma A/S of DENMARK |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.